What's known on the subject? and What does the study add? Today, angiogenesis is known
to play a key role in cancer growth and development. Emerging cancer treatments are based …

Interferon α (IFNα) is a cytokine that mediates diverse immune responses to tumours. It is the
oldest immune‐based oncologic drug and has been widely used to treat various …

Systemic lupus erythematosus (SLE) is characterized by increased vascular risk due to
premature atherosclerosis independent of traditional risk factors. We previously proposed …

Downregulation of miR-221-3p expression in prostate cancer (PCa) predicted overall and
cancer-specific survival of high-risk PCa patients. Apart from PCa, miR-221-3p expression …

Chlamydiae are obligate intracellular pathogens that are sensitive to pro-inflammatory
cytokine interferon-γ. IFN-γ-inducible murine p47 GTPases have been demonstrated to …

Interferon-α (IFN-α), a cytokine with marked therapeutic activity in transplantable tumor
models, has been identified as powerful angiogenesis inhibitor. The effects of IFN-α on the …

The purpose of the present study was to assess if guanylate-binding protein (GBP) mRNAs
could be prognostic biomarkers for patients with skin cutaneous melanoma (SKCM). The …

The use of genetically modified animals has been studied in scientific research over time as
a way to discover new treatments or even a cure for various diseases. Transgenic …

T-cell receptor (TCR) gene transfer for cancer immunotherapy is limited by the availability of
large numbers of tumor-specific T cells. TCR α and β chains were isolated from a highly lytic …

Interferon γ (IFN-γ) has recently been implicated in cancer immunosurveillance. Among the
most abundant proteins induced by IFN-γ are guanylate binding proteins (GBPs), which …